Business

enGene Reports Full Year 2025 Financial Results and Provides Business Update

BOSTON & MONTREAL, December 22, 2025--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, today announced its financial results for the full year ended October 31, 2025, and provided a business update.

U2Fx.comU2Fx.com
Dec 22, 2025 - 23:00
 0  10
enGene Reports Full Year 2025 Financial Results and Provides Business Update
BOSTON & MONTREAL, December 22, 2025--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage, non-viral genetic medicines company, today announced its financial results for the full year ended October 31, 2025, and provided a business update.
Read More

Tags:

Previous Article

Kalamazoo salon owner faces financial uncertainty after car crash damages business

Next Article

Suburban business cited for big oily asphalt spill in Chicago canal

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

U2Fx.com
U2Fx.com

Related Posts

Female students, leaders gather for Business of Her conference

Female students, leaders gather for Business of Her con...

U2Fx.com Apr 12, 2026  0  5

Scott’s Addition parking enforcement changes spark mixed reactions from residents, business owners

Scott’s Addition parking enforcement changes spark mixe...

U2Fx.com Dec 21, 2025  0  19

Celebrating Excellence: Honoring P&G’s Top-Performing External Business Partners

Celebrating Excellence: Honoring P&G’s Top-Performing E...

U2Fx.com Jan 26, 2026  0  14